Bramlage, P., Schmieder, R. E., Gitt, A. K., Baumgart, P., Mahfoud, F., Buhck, H., . . . Potthoff, S. A. (2015). The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: Insights from the prospective EARLY registry. Trials.
Style de citation ChicagoBramlage, Peter, Roland E. Schmieder, Anselm K. Gitt, Peter Baumgart, Felix Mahfoud, Hartmut Buhck, Taoufik Ouarrak, Martina Ehmen, et Sebastian A. Potthoff. "The Renin-angiotensin Receptor Blocker Azilsartan Medoxomil Compared With the Angiotensin-converting Enzyme Inhibitor Ramipril in Clinical Trials Versus Routine Practice: Insights From the Prospective EARLY Registry." Trials 2015.
Style de citation MLABramlage, Peter, et al. "The Renin-angiotensin Receptor Blocker Azilsartan Medoxomil Compared With the Angiotensin-converting Enzyme Inhibitor Ramipril in Clinical Trials Versus Routine Practice: Insights From the Prospective EARLY Registry." Trials 2015.